Biolidics Limited (SGX:8YY)
Singapore
· Delayed Price · Currency is SGD 0.0200
0.00 (0.00%)
At close: May 9, 2025
Biolidics Revenue
In the year 2024, Biolidics had annual revenue of 858.00K SGD with 176.77% growth. Biolidics had revenue of 714.00K in the quarter ending December 31, 2024, with 720.69% growth.
Revenue
858.00K
Revenue Growth
+176.77%
P/S Ratio
39.41
Revenue / Employee
122.57K
Employees
7
Market Cap
33.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 858.00K | 548.00K | 176.77% |
| Dec 31, 2023 | 310.00K | -2.35M | -88.35% |
| Dec 31, 2022 | 2.66M | 332.00K | 14.26% |
| Dec 31, 2021 | 2.33M | -6.94M | -74.88% |
| Dec 31, 2020 | 9.27M | 7.75M | 507.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DBS Group Holdings | 21.83B |
| Oversea-Chinese Banking Corporation | 13.78B |
| Singapore Telecommunications | 14.13B |
| United Overseas Bank | 13.37B |
| Singapore Technologies Engineering | 11.28B |
| Singapore Airlines | 19.35B |
| Wilmar International | 91.96B |
| Jardine Matheson Holdings | 48.83B |